Oligonucleotide API Market Is Forecast To Reach A Valuation Of US$ 5.36 Bn By The End Of 2030

NEWARK, Del., April 28, 2022 (GLOBE NEWSWIRE) -- According to FMI – an ESOMAR-certified market research firm, the global oligonucleotide API market is estimated to reach US$ 2.46 Bn in 2022, and witness a CAGR of 10.2% through 2030.

According to FMI's analysis, as of now, 100+ oligonucleotide APIs are in the clinical trials' phase, and regulatory approval is on the cards. Post-approval, the demand for production capacity will witness an exponentiation, thereby driving the oligonucleotide API market through 2030.

Oligonucleotides are being looked upon as the subsequent large group of therapeutics following biologics and molecules. This could be attributed to the assurance on their part to develop drugs at lower costs.

Apart from immune therapy, microbial and cardiovascular infections, and cancer, oligonucleotide APIs are being tried out to treat neurological disorders like Alzheimer's as well. However, factors like regulatory complexities and timely delivery of oligonucleotides (amidst Covid-19) are acting as restraints.

Get a Sample Copy of Report @

Key Takeaways from Oligonucleotide API Marker Study

• Antisense Oligonucleotides APIs are anticipated to reach US$ 4 Bn by 2030.
• North America and Europe collectively accounted for more than 47% of revenue share in 2019 while Asia Pacific is expected to grow at the fastest rate in the forecast period.
• Increase in use of antisense oligonucleotide APIs (especially post approval from US FDA in 2016) to boost the market in the forecast period
  

“Inorganic mode of growth coupled with broad therapeutic applications in gene therapy is expected to bolster the oligonucleotide API market” says the FMI analyst.

New Product Launches: Key Indicators to Oligonucleotide APIs Market

FMI has analyzed players such as Akcea Therapeutics, Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., and Dynavax Technologies in this report. According to the analysis, these players are consolidating their positions through new product launches.

For instance –

• In Mar 2020, Dynavax entered into collaboration with Clover Biopharmaceuticals for developing a vaccine candidate to combat Covid-19. Clover is into advanced evaluation of its Covid-19 S-Trimer, protein-based coronavirus vaccine candidate and Dynavax has its technical expertise along with proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018 for executing this.
• Alnylam Pharmaceuticals, Inc., in 2018, launched Givlaari and Onpattro at the commercial level.

Ask for Customization @

Gene Therapy and Oligonucleotide APIs

Synthetic oligonucleotides are being used in gene therapy for inactivating genes that help in propagating the disease. Antisense oligonucleotide APIs are used for disrupting the faulty gene's transcription.

Also, siRNA could be used for signaling the cell to disrupt faulty mRNA's translation. Along these lines, Pharmamar, in Jan 2020, signed an agreement with Jazz Pharmaceuticals for selling the API for“lurbinectedin”, one of the late-phase treatments for SCLC (small cell lung cancer) so that the latter could commercialize it.

Want more insights?

The study provides compelling insights on Oligonucleotide API market on basis of API type in detail cover every aspects of the market such as Antisense Oligonucleotides API, Short Interfering RNA (siRNA) API, Phosphorodiamidate Morpholino Oligonucleotides (PMO) API, MiRNA API, Aptamers API, CpG Oligonucleotides API and Others (ON Conjugates (NP), ShRNA, etc.), Marketing Status (Marketed, Clinical Trials (Clinical Phases)), and end users (Pharmaceutical Companies and Biotechnology Companies)) across seven major regions. 

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Technology Assessment

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

TOC continued..!

Contact Sales for Further Assistance in Purchasing this Report@

Have a Look at Related Research Reports:

Phenytoin Testing Market - The phenytoin testing market is likely to record a strong CAGR of1.4 % during the forecast period. The phenytoin testing market is currently valued at US$ 6.6 Bn in 2022 and is likely to reach US$ 7.58 Bn by 2032.

Body Contouring Market - The body contouring market is expected to record a CAGR of 6.9% during the forecast period 2022-2032, up from US$ 7.3 Billion in the year 2022 to reach a valuation of US$ 11.1 Billion by 2032.

Brain Biomarkers Market - The global brain biomarkers market is anticipated to exhibit growth at a CAGR of 14.3% in the forecast period from 2022 to 2032. It is set to reach US$ 8.3 Billion in 2022 and US$ 11.5 Billion in 2032.

Lab Robotics Market - The global lab robotics demand reached over US$ 186 Million in 2022 and is forecast to grow at a robust CAGR of around 6.8% between 2022 and 2032, totaling approximately US$ 300 Million by 2032.

Magnetic Resonance Imaging (MRI) Market - The magnetic resonance imaging (MRI) market is projected to record a CAGR of 5.7% during the forecast period, up from US$ 7.9 Bn in 2021 to reach a valuation of US$ 12.2 Bn by 2028.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware - 19713, USA

T: +1-845-579-5705

For Sales Enquiries:

Website:

Report:

LinkedIn | Twitter | Blogs

Tags Oligonucleotide API Market Oligonucleotide API Oligonucleotide API Industry Antisense Oligonucleotides API Clinical Trials Related Links

• Calprotectin Testing Market Outlook (2022-2032)
• Anatomic Pathology Market Outlook (2022-2030)
• Compression Therapy Market Outlook (2022-2030)
• Bacteriophage Market Outlook (2021-2031)
• Patient Lateral Transfer Market Outlook (2022-2030)
• Biopharmaceutical Contract Manufacturing Market Outlook (2022-2029)
• Veterinary Imaging Market Outlook (2022-2030)
• Cell Culture Media Bags Market Outlook (2022-2030)
• Dermatology Lasers Market Outlook (2022-2030)
• Stethoscope Market Outlook (2022-2030)

MENAFN28042022004107003653ID1104116946